Cancer Research and Treatment

Sang-Sik Ha

1 Article

Intensity of Tumor Budding as an Index for the Malignant Potential in Invasive Rectal Carcinoma: Sang-Sik Ha, Hong-Jo Choi, Ki-Jae Park, Jung-Min Kim, Sung-Heun Kim, Young-Hoon Roh, Hyuk-Chan Kwon, Mee-Sook Roh; Cancer Res Treat. 2005;37(3):177-182. Published online June 30, 2005; DOI: https://doi.org/10.4143/crt.2005.37.3.177

Purpose

The aim of this study was to quantitatively assess the intensity of tumor budding in rectal carcinoma and to determine how it correlates with the malignant potential.

Materials and Methods

Intensities of the tumor budding at the invasive front of the surgical specimens from 90 patients (male, 51) with well- or moderately-differentiated rectal carcinoma were investigated. Differences in the budding intensity among pathologic variables were compared, and recurrences and survivals were analyzed in accordance with degree of the budding intensity. The patients ranged in age from 33 to 75 years (mean, 55.4) with the median follow-up being 43 months (range, 12~108).

Results

Tumor budding was identified in 89 patients (98.9%) with a mean intensity of 7.5±5.3. The budding intensity was significantly higher in tumors with lymphatic invasion (p=0.0081), blood vessel invasion (p<0.0001), and perineural invasion (p=0.0013) than in those tumor without these findings. It became significantly higher with the increase in nodal stage (p<0.0001). The intensity of tumor budding in patients with relapse (29 patients) was significantly higher than that in patients without relapse (6.2±5.0 vs. 10.2±4.9; p=0.0005), but this difference in the intensity was observed only for the node-positive patients (8.0±3.4 vs. 11.9±5.1; p=0.0064). When the patients were stratified into two groups on either side of the mean of the intensity, the higher intensity group showed a significantly less favorable disease-free (DFS) and overall survival (OS) (p=0.0026 and 0.0205, respectively). Based on the multivariate analysis, the nodal stage and the intensity of budding proved to be the independent variables associated with DFS (p=0.023 and 0.03, respectively).

Conclusion

Tumor budding at the invasive margin is a reliable pathologic index that indicates a higher malignant potential and a less favorable prognosis for patients with advanced rectal carcinoma.

Citations

Citations to this article as recorded by

Polyploid giant cancer cells and cancer progression
Xinyue Zhou, Mingming Zhou, Minying Zheng, Shifeng Tian, Xiaohui Yang, Yidi Ning, Yuwei Li, Shiwu Zhang
Frontiers in Cell and Developmental Biology.2022;[Epub] CrossRef
Tumor Budding as a Prognostic Marker in Rectal Cancer Patients on Propensity Score Analysis
Jung Kyong Shin, Yoon Ah Park, Jung Wook Huh, Seong Hyeon Yun, Hee Cheol Kim, Woo Yong Lee, Seok Hyung Kim, Sang Yun Ha, Yong Beom Cho
Annals of Surgical Oncology.2021; 28(13): 8813. CrossRef
Immunohistochemical evaluation of tumor budding for stratifying T1 colorectal cancer: optimal cut-off value and a novel computer-assisted semiautomatic method
Manabu Takamatsu, Hiroshi Kawachi, Noriko Yamamoto, Maki Kobayashi, Yuka Toyama, Takashi Maekawa, Akiko Chino, Shoichi Saito, Masashi Ueno, Yutaka Takazawa, Yuichi Ishikawa
Modern Pathology.2019; 32(5): 675. CrossRef
Tumor Budding: Prognostic Value in Muscle-invasive Bladder Cancer
Laura Lorenzo Soriano, Guzmán Ordaz Jurado, José Luis Pontones Moreno, Sara Villarroya Castillo, Soraya Hernández Girón, Iván Sáez Moreno, David Ramos Soler
Urology.2019; 130: 93. CrossRef
RAS, Cellular Plasticity, and Tumor Budding in Colorectal Cancer
Valeria Maffeis, Lorenzo Nicolè, Rocco Cappellesso
Frontiers in Oncology.2019;[Epub] CrossRef
Prognostic Impact of Tumor-Budding Grade in Stages 1–3 Colon Cancer: A Retrospective Cohort Study
Bo Young Oh, Yoon Ah Park, Jung Wook Huh, Seong Hyeon Yun, Hee Cheol Kim, Ho-Kyung Chun, Seok Hyung Kim, Sang Yun Ha, Woo Yong Lee, Yong Beom Cho
Annals of Surgical Oncology.2018; 25(1): 204. CrossRef
Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching
Linde De Smedt, Sofie Palmans, Daan Andel, Olivier Govaere, Bram Boeckx, Dominiek Smeets, Eva Galle, Jasper Wouters, David Barras, Madeleine Suffiotti, Jeroen Dekervel, Thomas Tousseyn, Gert De Hertogh, Hans Prenen, Sabine Tejpar, Diether Lambrechts, Xavi
British Journal of Cancer.2017; 116(1): 58. CrossRef
Tumour budding in colorectal cancer: what do we know and what can we do?
Linde De Smedt, Sofie Palmans, Xavier Sagaert
Virchows Archiv.2016; 468(4): 397. CrossRef
Tumor Budding: The Name is EMT. Partial EMT.
Alexandru Grigore, Mohit Jolly, Dongya Jia, Mary Farach-Carson, Herbert Levine
Journal of Clinical Medicine.2016; 5(5): 51. CrossRef
The relationship between tumour budding, the tumour microenvironment and survival in patients with primary operable colorectal cancer
Hester C van Wyk, James H Park, Joanne Edwards, Paul G Horgan, Donald C McMillan, James J Going
British Journal of Cancer.2016; 115(2): 156. CrossRef
Tumor Budding, Micropapillary Pattern, and Polyploidy Giant Cancer Cells in Colorectal Cancer: Current Status and Future Prospects
Shiwu Zhang, Dan Zhang, Zhengduo Yang, Xipeng Zhang, Chuanwei Yang
Stem Cells International.2016;[Epub] CrossRef
The role of tumour budding in predicting survival in patients with primary operable colorectal cancer: A systematic review
H.C. van Wyk, James Park, Campbell Roxburgh, Paul Horgan, Alan Foulis, Donald C. McMillan
Cancer Treatment Reviews.2015; 41(2): 151. CrossRef
Tumour Budding and Survival in Stage II Colorectal Cancer: a Systematic Review and Pooled Analysis
F. Petrelli, E. Pezzica, M. Cabiddu, A. Coinu, K. Borgonovo, M. Ghilardi, V. Lonati, D. Corti, S. Barni
Journal of Gastrointestinal Cancer.2015; 46(3): 212. CrossRef
Tumor Budding in Colorectal Carcinoma
Rondell P. Graham, Robert A. Vierkant, Lori S. Tillmans, Alice H. Wang, Peter W. Laird, Daniel J. Weisenberger, Charles F. Lynch, Amy J. French, Susan L. Slager, Yassaman Raissian, Joaquin J. Garcia, Sarah E. Kerr, Hee Eun Lee, Stephen N. Thibodeau, James
American Journal of Surgical Pathology.2015; 39(10): 1340. CrossRef
Tumor budding in the clinical management of colon and rectal cancer
Viktor H Koelzer, Inti Zlobec, Alessandro Lugli
Colorectal Cancer.2014; 3(4): 387. CrossRef
Tumour budding and the expression of cancer stem cell marker aldehyde dehydrogenase 1 in nasopharyngeal carcinoma
Wei‐Ren Luo, Fei Gao, Si‐Yi Li, Kai‐Tai Yao
Histopathology.2012; 61(6): 1072. CrossRef
Tumor budding in colorectal carcinoma: time to take notice
Bojana Mitrovic, David F Schaeffer, Robert H Riddell, Richard Kirsch
Modern Pathology.2012; 25(10): 1315. CrossRef
Prognostic significance of tumor budding in gastrointestinal tumors
Bruno Märkl, Hans M Arnholdt
Expert Review of Anticancer Therapy.2011; 11(10): 1521. CrossRef
The Prognostic Significance of Fascin Expression in Colorectal Carcinoma
Jeong Min Lee, Jong Hun Lee, Mee Sook Roh, Ki Jae Park
Intestinal Research.2010; 8(2): 117. CrossRef

9,503 View
50 Download
19 Crossref

Author index